HIGHLIGHTS
- who: Lili Wang and collaborators from the Fudan University, China have published the Article: Efficacy and survival analysis of nimotuzumab combined with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma, in the Journal: (JOURNAL)
- how: The authors used a subgroup analysis method to compare the efficacy of chemoradiotherapy combined with NTZ in different subgroups. Ltd) was used in the study group (NTZ-CCRT). The survival results were calculated by the Kaplan-Meier method and the survival differences Different levels of hsCRP before treatment may have affected the efficacy of the addition of NTZ . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.